Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-28 @ 5:03 PM
Study NCT ID:
NCT00687804
Status:
COMPLETED
Last Update Posted:
2013-04-01
First Post:
2008-05-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study
Sponsor:
Novartis
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CRFB002D2301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None